AbbVie
ABBV
#30
Rank
โ‚ฌ393.00 B
Marketcap
222,44ย โ‚ฌ
Share price
4.20%
Change (1 day)
40.77%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ125.61 Billion

According to AbbVie's latest financial reports the company's total liabilities are โ‚ฌ125.61 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ116.78 B-7.79%
2024-12-31โ‚ฌ126.65 B12.63%
2023-12-31โ‚ฌ112.45 B-0.73%
2022-12-31โ‚ฌ113.28 B-2.13%
2021-12-31โ‚ฌ115.75 B3.57%
2020-12-31โ‚ฌ111.76 B28.69%
2019-12-31โ‚ฌ86.84 B46.54%
2018-12-31โ‚ฌ59.26 B8.25%
2017-12-31โ‚ฌ54.74 B-6.31%
2016-12-31โ‚ฌ58.43 B30.11%
2015-12-31โ‚ฌ44.91 B111.94%
2014-12-31โ‚ฌ21.18 B18.45%
2013-12-31โ‚ฌ17.88 B0.08%
2012-12-31โ‚ฌ17.87 B205.89%
2011-12-31โ‚ฌ5.84 B43.1%
2010-12-31โ‚ฌ4.08 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚ฌ102.91 B-18.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ74.96 B-40.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ73.14 B-41.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ9.50 B-92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ28.83 B-77.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ58.27 B-53.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ58.50 B-53.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ52.84 B-57.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ1.31 B-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA